A Guide to Fiscal Year 1991 Federal Funding for HIV Disease: How Dollars are Spent How to Access Them

4. Perinatal HIV-Prevention Projects

Goals of the perinatal demonstration research projects, located in San Francisco, New York City,
Baltimore, Philadelphia, Miami, and northern New
Jersey, are to determine and overcome obstacles that
prevent effective use of contraception among women
who have HIV infection or are at high risk for HIV
infection; to reduce acquisition of HIV infection
through consistent use of condoms; to facilitate use
of family planning services by these women; to
evaluate attitudinal factors related to contraception
among women at high risk for infection or infected
with HIV; and to encourage behavioral change
among these women to reduce their risk of acquisition or transmission of HIV.
5. HIV Community Demonstration Projects
HIV Community Demonstration Projects (funded
in Seattle, Denver, Long Beach, New York, and
Chicago) are flexible, community-based research
efforts for the development, implementation, and
evaluation of interventions to decrease the probability
of HIV transmission in a community. These projects,
in existence since 1985, focused the first four years
on men who have sex with men. In 1990 the projects
were redesigned to operate as multi-site projects,
each electing to intervene with three of the following most difficult to reach groups: men who have sex
with men but do not self-identify as gay or bisexual;
intravenous-drug users not in treatment; female sex
partners of the first two groups; prostitutes (male and
female); and runaway or "throwaway" high-risk
adolescents.
6. The United States Conference of Mayors (USCM)
Through a cooperative agreement with the USCM,
CPS provides "seed" funds to newly emerging CBOs
interested in conducting HIV-prevention activities.
These grants are non-renewable, one-year awards of
up to $50,000, and are available for health education/risk reduction programs. See Appendix C for
information on contacting the USCM.
7. National Conference of State Legislators (NCSL)
CPS provides financial and technical assistance to
NCSL which, in turn, passes it on to state legislatures
in the form of publications and reports.
For more information about CPS HIV programs
contact:
Ronald O. Valdiserri, M.D., M.P.H.
404/639-1480

Mary Wallingham
404/639-1480
Center for Infectious Diseases
The Center for Infectious Diseases (CID) is
involved in the following programs related to fulfillment of CDC's four HIV-related operational goals.
CID FY 1991-appropriated AIDS/HIV funding is
$120,995,549. Programs conducted by CID are
tied to three of CDC's four AIDS/HIV goals.
CID activities related to Goal 1 center on
surveillance and epidemiologic and laboratory-based
investigations, including: providing financial support
and technical consultation to state and local health
departments for surveillance activities; conducting
national surveillance of HIV infection through a family of sentinel HIV seroprevalence surveys and other
studies; collecting AIDS/HIV data through state and
local health departments, surveys of special populations, and sentinel HIV-surveillance programs at
selected hospitals (in conjunction with NCHS);
developing and using computer-based AIDS/HIV
reporting systems; reporting collected data in AIDS/
HIV surveillance monthly and annual reports; conducting studies on behavioral and biologic transmission factors, including studies of occupational
infection-control practices and the effectiveness of
personal protective equipment (in conjunction with
NIOSH); studying the natural history of HIV disease;
defining the serology and molecular virology of
HIV-1 and HIV-2; initiating studies to more clearly
define HIV biologic structures and functions that may
be susceptible to drug intervention or vaccine
development; determining the incidence, prevalence,
risk factors, and pathogenesis of the neurologic and
neuropsychologic dysfunction associated with HIV
infection; assessing efficacy of anti-TB drug
regimens among TB patients with HIV infection;
conducting preventive therapy efficacy studies
among persons with both TB and HIV infection (in
conjunction with CPS); and conducting autopsy
studies in endemic areas to assess the frequency of
HIV infection among persons who die without AIDS
diagnosis (in conjunction with CPS).
CID activities related to Goal 3 focus on developing prevention technologies and promoting scientific
knowledge in public policy and public health practice, including: anticipating trends in the AIDS/HIV
epidemic through statistical modeling; developing
and evaluating new diagnostic tests for HIV infection, including serologic and viral isolation tech
niques; expanding laboratory support for surveillance
and epidemiologic studies of HIV-1 and HIV-2; con
50

Reproduction By Permission Only

~1991 ASAP

50 Reproduction By Permission Only ~1991 ASAP